Pipeline
Developing non-opioid therapeutics across pain and fever indications
Our pipeline includes orally and intravenously delivered candidates designed to address acute pain, neuropathic pain, and related indications.
Stages
Clinical development
We are developing oral and IV formulations of SRP compounds optimized for distinct clinical indications. Preclinical and clinical data support their potential for use in acute, chronic, and neuropathic pain.
For pain
Formula
Program
R&D
IND-Enabling
Phase 1
Phase 2
Phase 3
SRP-001 Oral
Acute & Chronic Pain
Neuropathy - Diabetic and Chemotherapy
SRP-001 IV
Acute Post-Operative Pain
SRP-001 Topical
Ocular
Oral
Phase 2
Acute & Chronic Pain
Phase 1
Neuropathy - Diabetic and Chemotherapy
IV
IND-Enabling
Acute Post-Operative Pain
Topical
IND-Enabling
Ocular
Proprietary Innovation
Versatile applications
SRP compounds are being developed for multiple clinical contexts—acute, chronic, and neuropathic pain; as well as in-hospital settings with an intravenous formulation—with a focus on organ-sparing safety and non-addictive mechanisms.
Let's get in touch
